Home Cart 0 Sign in  

[ CAS No. 247068-81-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 247068-81-1
Chemical Structure| 247068-81-1
Structure of 247068-81-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 247068-81-1 ]

Related Doc. of [ 247068-81-1 ]

Alternatived Products of [ 247068-81-1 ]

Product Details of [ 247068-81-1 ]

CAS No. :247068-81-1 MDL No. :MFCD26227261
Formula : C14H25NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :BRMIWZWAGRRHEN-NSHDSACASA-N
M.W : 255.35 Pubchem ID :57661775
Synonyms :

Calculated chemistry of [ 247068-81-1 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.71
Num. rotatable bonds : 8
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 73.65
TPSA : 55.4 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.95
Log Po/w (XLOGP3) : 3.37
Log Po/w (WLOGP) : 3.07
Log Po/w (MLOGP) : 2.16
Log Po/w (SILICOS-IT) : 2.57
Consensus Log Po/w : 2.82

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.02
Solubility : 0.245 mg/ml ; 0.000959 mol/l
Class : Soluble
Log S (Ali) : -4.21
Solubility : 0.0157 mg/ml ; 0.0000614 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -2.89
Solubility : 0.326 mg/ml ; 0.00128 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.25

Safety of [ 247068-81-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 247068-81-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 247068-81-1 ]
  • Downstream synthetic route of [ 247068-81-1 ]

[ 247068-81-1 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 50-00-0 ]
  • [ 247068-81-1 ]
YieldReaction ConditionsOperation in experiment
92% With piperidine; piperdinium acetate In tetrahydrofuran at 68℃; for 8 h; Green chemistry A solution of compound 3R1 (4 mmol) in anhydrous THF (10 mL)was heated with piperidinium acetate (14.8 mmol), piperidine (9.9mmol) and paraformaldehyde (39.6 mmol). The reaction mixture wasrefluxed for 8 h at 68 °C. The solution was extracted with ethyl acetate(3 × 15 mL) and washed with 1 M HCl (40 mL) and brine (40 mL) andthen dried over anhydrous Na2SO4. The solvent was evaporated and thecrude product was purified by flash column chromatography with ethylacetate and petroleum (V/V = 1:10) to give 4R1.Colourless liquid; yield 92percent; 1H NMR (400 MHz, CDCl3): δ 0.89(–CH3, d, J = 6.6 Hz, 3H), 0.99 (–CH3, d, J = 6.6 Hz, 3H), 1.32 (–CH,ddd, J = 14.4, 9.6, 4.8 Hz, 1H), 1.42 (–CH3, s, 9H), 1.50–1.44 (–CH,m, 1H), 1.76–1.71 (–CH, m, 1H), 1.89 (–CH3, s, 3H), 5.05 (–CH, dd,J = 9.6, 3.6 Hz, 1H), 5.14 (–CH, d, J = 8.4 Hz, 1H), 5.87 (–CH, s, 1H),6.07 (–CONH, s, 1H); MS (ESI) m/z: 256.3 [M + H]+, 278.3 [M + Na]+;HRMS calcd for C14H25NO3Na [M + Na]+: 278.1726; found: 278.1734.
78.7% With piperidine; piperidinyl acetate In tetrahydrofuran for 3 h; Reflux 0.4 mol of (S) -4-tert-butoxycarbonylamino-6-methyl-3-heptanone (2) was weighed and dissolved in 400 ml of tetrahydrofuran, Add 1.5 mol piperidine acetate and 1.0mol Piperidine and 2.0 moles of formaldehyde, Reflux 3h, then add 2.0mol formaldehyde, TLC check Test to complete, add appropriate amount of water after extraction with ethyl acetate, were washed with 1N dilute hydrochloric acid, saturated brine 1 times, organic phase Dried to give 0.31 mol of product (3) in a yield of 78.7percent.
59.1% With sodium hydroxide In water at 65 - 70℃; for 3.08 h; In a thermometer,A constant-pressure dropping funnel and a glass stopper in a 50 mL three-necked flask,Compound II (0.5 g, 0.002 mol) was added sequentially, Sodium hydroxide (0.16 g, 0.004 mol),Formaldehyde aqueous solution (0.012 mol),And methanol was added:Purified water = 1: 1 mixed solvent 15mL,Stirring vigorously for 5 min, So that the material dissolved completely.Water bath temperature control 65 ~ 70 ° C conditions,Reaction 3h,TLC detection of raw materials complete reaction is completed. The system was cooled to room temperature,And quenched by the addition of 50 mL of purified water,The product was extracted by addition of 50 mL of ethyl acetate, The ethyl acetate phase was washed twice with 50 mL of saturated brine,Then dried with Na2S04,The solvent was distilled off under reduced pressure,Crude product with PE: ΕΑ = 20: 1 eluent column chromatography,To give a colorless oil, 31 g, yield 59.1percent
Reference: [1] Journal of Chemical Research, 2016, vol. 40, # 2, p. 82 - 86
[2] Patent: CN105017181, 2017, B, . Location in patent: Paragraph 0073; 0074; 0075
[3] Patent: CN105294501, 2016, A, . Location in patent: Paragraph 0064-0066
  • 2
  • [ 6386-71-6 ]
  • [ 87694-50-6 ]
  • [ 247068-81-1 ]
YieldReaction ConditionsOperation in experiment
92% at -78℃; for 2.5 h; The second (right hand) molecular fragment can be made in parallel or in sequence. This procedure involves alkenylating a Weinreb amide of an amino terminal protected amino acid. For example, an amino terminal protected amino acid can be reacted with a reagent (for example, MeNHOMeHCl, EDCl, NMM, HoBt, DMF, 0, 12 h, 80percent) to make a Weinreb amide of the carboxyl terminus of the amino acid. Alkenylation is carried out by exposing the Weinreb amide to an alkenylating agent (for example, propen-2-yl lithium) to give an ?','-unsaturated ketone. For example, for an epoxomicin synthesis, Boc-Leu Weinreb amide can be reacted with propen-2-yl lithium to give the corresponding ?','-unsaturated ketone. Propen-2-yl lithium can be generated by reaction of 2-bromopropene with t-butyl lithium in a non-protic solvent (for example, diethyl ether) at low temperature (for example -78 C.), for at least 30 minutes (for example 2.5 hours) to give the ?','-unsaturated ketone in excellent yield (for example, 92percent).
Reference: [1] Patent: US6831099, 2004, B1, . Location in patent: Page column 13-14
  • 3
  • [ 13291-18-4 ]
  • [ 87694-50-6 ]
  • [ 247068-81-1 ]
YieldReaction ConditionsOperation in experiment
7.5 g at 0 - 5℃; for 6 h; Inert atmosphere To a 0 °C solution of (I) (10.0 g, 36.4 mmol,) in 100 mL of dry THF, under an atmosphere of argon was added isopropenyl magnesium bromide (364 mL, 182 mmol, 5.0 eq, 0.5 M solution in THF) dropwise using an addition funnel. The rate of addition was adjusted such that the internal reaction temperature was maintained below 5 °C. After six hoursthe reaction mixture was poured into 250 mL of sat. NH4Cl and 500 mL wet ice. After stirring for 30 minutes the mixture became clear and the volatiles were removed under reduced pressure and the crude material was diluted with EtOAc (200mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 x 150 mL), the organic layers were combined, washed with water (2 x 150 mL), brine (2 x 150 mL) and dried over MgSO4. The MgSO4 was removed by filtration and the volatiles were removed under reduced pressure. Purification by flash chromatography (15:1 hexanes/ EtOAc) gave (J) as a solid (7.5 g, 29.37 mmol).
72 g at 25 - 40℃; for 2.75 h; EXAMPLE 11: Preparation of te -butyl ((4S)-2,6-dimethyl -3-oxo hept-l-en-4- yl))carbamate of Formula XVIII A mixture of compound of Formula XVII (100 g) and toluene (1500 ml) was heated to 75- 80°C and was distilled completely under vacuum at same temperature to obtain residue. The obtained residue was dissolved in tetrahydrofuran (100 ml) at 25-30°C. In another reaction flask isopropenyl magnesium bromide (2.19 lit) was charged at 25-30°C and slowly added the above tetrahydrofuran solution over 2 hr at 25-40°C and stirred for 45 min at same temperature. After completion of the reaction, quenched the reaction mass in to 15percent ammonium chloride (1.5 lit) at 0-5 °C and organic layer was separated and concentrated under vacuum at below 40°C to obtain residue. The obtained residue was purified by silicycle silica by using ethyl acetate and cyclohexane solvent system. Product containing solvent fractions were combined and concentrated under vacuum at below 40°C to obtain residue. The obtained residue was dissolved in acetone (100 ml) at 25-30°C and allowed to cool to -5 to 0°C. To the clear solution water (1.5 lit) was added slowly at -5 to 0°C. Precipitated solid was filtered, washed with water (100 ml) and dried to get the title compound as a crystalline solid. Yield: 72 g; PXRD: Fig. 9; Chemical purity by HPCL: 99.44percent; Chiral purity by HPLC: 99.73percent.
Reference: [1] ChemBioChem, 2012, vol. 13, # 6, p. 810 - 817
[2] Patent: WO2013/9923, 2013, A1, . Location in patent: Sheet 4
[3] Chemistry and Biology, 2014, vol. 21, # 6, p. 782 - 791
[4] Bioorganic and Medicinal Chemistry, 2018,
[5] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 2955 - 2965
[6] Patent: KR2015/131405, 2015, A, . Location in patent: Paragraph 0526-0528
[7] Patent: WO2016/185450, 2016, A1, . Location in patent: Page/Page column 66
[8] European Journal of Medicinal Chemistry, 2019, vol. 161, p. 416 - 432
  • 4
  • [ 557-93-7 ]
  • [ 87694-50-6 ]
  • [ 247068-81-1 ]
YieldReaction ConditionsOperation in experiment
38.5 g
Stage #1: With iodine; magnesium In tetrahydrofuran at 50 - 55℃; for 2.5 h; Inert atmosphere
Stage #2: at 0 - 30℃; for 8.25 h;
A mixture of magnesium (24 gm), iodine (0.5 gm) and tetrahydrofuran (1000 ml) was heated to 50-55°C under nitrogen atmosphere. A solution of 2-bromo propene (123.5 gm) in tetrahydrofuran (250 ml) was slowly added lot wise to the reaction mixture at 50-55°C and stirred the reaction mixture for 2 hrs 30 min at the same temperature. Cooled the reaction mixture to 25-30°C and the resulting reaction mixture was added to a pre-cooled mixture of (S)-tert-butyl l-(methoxy(methyl)amino)-4-methyl-l-oxopentan-2-ylcarbamate (50 gm) and tetrahydrofuran at 0-5°C and stirred the reaction mixture for 15 min at the same temperature. Raised the temperature of the reaction mixture to 25-30°C and stirred for 8 hrs at the same temperature. The obtained reaction mixture was slowly added to a pre-cooled mixture of water and ammonium chloride at 0-5°C and stirred for 30 min at the same temperature. Neutralized the reaction mixture using aqueous hydrochloric acid solution and stirred the reaction mixture for 15 min. Both the organic and aqueous layers were separated and the aqueous layer was extracted with ethyl acetate. Combined the organic layers and distilled off the solvent completely under reduced pressure. Dichloromethane was added to the obtained compound at 25-30°C and stirred for 5 min. Silica gel was added to the reaction mixture and distilled off the solvent completely from the reaction mixture. Cooled the obtained compound to 25-30°C, cyclohexane (247.5 ml) and ethyl acetate (2.5 ml) were added and stirred the reaction mixture for 45 min at the same temperature. Filter the reaction mixture and distill off the solvent completely from the filtrate under reduced pressure to get the title compound. Yield: 38.5 gm.
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 30, p. 5710 - 5718
[2] Patent: WO2016/170544, 2016, A1, . Location in patent: Page/Page column 35; 36
  • 5
  • [ 87694-50-6 ]
  • [ 106-95-6 ]
  • [ 247068-81-1 ]
Reference: [1] Patent: WO2014/18807, 2014, A1, . Location in patent: Paragraph 00112; 00114
  • 6
  • [ 557-93-7 ]
  • [ 173899-64-4 ]
  • [ 247068-81-1 ]
YieldReaction ConditionsOperation in experiment
83 %Chromat. With isopropylmagnesium chloride; magnesium In tetrahydrofuran; n-heptane at -10 - 42℃; for 3 h; Inert atmosphere (S)-tert-butyl (4-methyl-i -morpholino-oxopentan-2-yl)carbamate (1.0 eq)dissolved in THF (3 mL per gm) and heptane (1 mL per gm) was charged to a reaction vessel that was flushed with nitrogen gas. THF (3 mL per gm) and heptanes (1 mL per gm) were added to bring the solution to a total of 8 mL per gm morpholino starting material. Magnesium powder (2.2 eqs; Sigma Aldrich or Alfa Aesar) was added and the solution was cooled -10°C to -5°C. i-PrMgC1 (2.OM solution in THF; 1.0 eq) was added tothe reaction while maintaining the temperature between - 10°C and 0°C. The solution was then warmed to 35°C and 2-bromopropene (0.15 eq) was added. The temperature was monitored to observe initiation of the Grignard reaction which results in about a 5-10°c exotherm. Once the termperature dropped to 99percent conversion was observed by HPLC. The solution was cooled to ambient temperature, then added to a reaction vessel containing citric acid (8 mL per gm of morpholino starting material, 30percent w/w in H20) and heptane (2 mL per gm) cooled to-10°C to -5°C, while maintaining the temperature between -10°C to -5°C. During thequench it was important to keep the unquenched reaction solution stirring, as the stagnantsolution could solidify and cause clogging of the pump. The quenched solution was warmed to ambient temperature and stirred for 15-30 minutes and the aqueous layer was removed. Water (5 mL per gm) was added over 5-30 minutes while maintaining the temperature at 15-30°C. The mixture was stirred for 15-30 minutes and the aqueous layerwas removed. 5i02 (2 gm/gm, 6Oum 70-23 0 mesh) was added to the solution and the slurry was stirred for 15-30 minutes. The slurry was then filtered through a wet pad of5i02 (2 gm 5i02/gm of morpholino starting material), washed with 2percent IPAc in heptanes(10 mL per gm). The solution was concentrated to afford Intermediate 1, which was eitherstored for later use or immediately used in the next step. Yield: 83percent (based on HPLC assay). This method of generating the morpholino intermediate above is efficient as it reduced the volume of previous methods from 50 V to 25 V and tedious and time consuming column chromatography for purification was replaced with a silica gel plug filtration. The product of example 1 was isolated from Boc-L-Leu•monohydrate with anassay yield of 75percent over two steps.
Reference: [1] Patent: WO2018/27021, 2018, A1, . Location in patent: Page/Page column 25; 26; 27
  • 7
  • [ 1888-75-1 ]
  • [ 87694-50-6 ]
  • [ 247068-81-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 15, p. 2283 - 2288
  • 8
  • [ 13139-15-6 ]
  • [ 247068-81-1 ]
Reference: [1] ChemBioChem, 2012, vol. 13, # 6, p. 810 - 817
[2] Patent: WO2013/9923, 2013, A1,
[3] Patent: WO2014/18807, 2014, A1,
[4] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 2955 - 2965
[5] Organic and Biomolecular Chemistry, 2014, vol. 12, # 30, p. 5710 - 5718
[6] Journal of Chemical Research, 2016, vol. 40, # 2, p. 82 - 86
[7] Patent: KR2015/131405, 2015, A,
[8] Patent: WO2016/170544, 2016, A1,
[9] Patent: WO2016/185450, 2016, A1,
[10] Patent: CN105294501, 2016, A,
[11] Patent: CN106316887, 2017, A,
[12] Patent: WO2018/27021, 2018, A1,
[13] European Journal of Medicinal Chemistry, 2019, vol. 161, p. 416 - 432
[14] Bioorganic and Medicinal Chemistry, 2018,
  • 9
  • [ 87694-50-6 ]
  • [ 247068-81-1 ]
Reference: [1] Journal of Chemical Research, 2016, vol. 40, # 2, p. 82 - 86
[2] Patent: CN105017181, 2017, B,
[3] Patent: CN106316887, 2017, A,
  • 10
  • [ 61-90-5 ]
  • [ 247068-81-1 ]
Reference: [1] Patent: WO2016/170544, 2016, A1,
[2] Patent: CN105294501, 2016, A,
  • 11
  • [ 24424-99-5 ]
  • [ 247068-81-1 ]
Reference: [1] Patent: WO2016/170544, 2016, A1,
[2] Patent: CN105294501, 2016, A,
  • 12
  • [ 63096-02-6 ]
  • [ 247068-81-1 ]
Reference: [1] Patent: CN106316887, 2017, A,
  • 13
  • [ 247068-81-1 ]
  • [ 247068-82-2 ]
YieldReaction ConditionsOperation in experiment
85% With (R)-La-BINOL; triphenylphosphine; <i>tert</i>-butyl alcohol In toluene at 20℃; for 0.5 h; Compound III (102 g, 0.4 mol), asymmetric chiral catalyst (R) -La-BINOL (3.24 g, 2 molpercent) was added to a 1 L reaction flask,Triphenylphosphine (14.8 g, 20 molpercent), 500 mL of toluene, and stirred at room temperature.Then, tert-butanol (108 g, 1.2 mol) was slowly added dropwise. After 0.5 h of reaction, TLC was monitored and the reaction was complete. The reaction solution was filtered and the filtrate was collected.The filtrate was quenched with 300 mL of saturated sodium sulfite solution. The tetrahydrofuran was evaporated under reduced pressure and then extracted with 400 mL of ethyl acetate. The organic phase was washed successively with 100 mL of water, 100 ml of saturated brine, dried over anhydrous sodium sulfate and dried under reduced pressure. 92 g of a pale yellow oil, which was Compound I, yield 85.0percent and ee was 93percent.
40% With tetramethyl ammoniumhydroxide; urea hydrogen peroxide adduct In methanol; benzonitrile at -10℃; for 20 h; Inert atmosphere To a solution of tert-butyl (S)-(2,6-dimethyl-3-oxohept-1-en-4 yl)carbamate (10 g, 37.2 mmol) in MeOH (80 ml) cooled to -10 °C, benzonitrile (8.4 ml, 82 mmol), hydrogen peroxide-urea adduct (14 g, 149 mmol) and tetramethylammonium hydroxide (6.9 g, 37.2 mmol) were added dropwise. The reaction mixture was stirred at -10 °C under N2 atmosphere for 20 h. After dilution with a saturated Na2S20 3 solution (120 ml) and 1 M HCI (7 ml), MeOH was evaporated under reduced pressure and the aqueous phase was extracted with EtOAc (50 ml x 3). The combined organic phases were dried over MgS04 and concentrated in vacuo affording a crude which was suspended in toluene (40 ml), stirred at 0-5 °C for 1 h, and filtered. The resulting solution was concentrated in vacuo affording a crude oil (7.45 g) containing tert-butyi((S)-4-methyi-1-((R)-2-methyloxiran-2-yl)1-oxopentan-2-yl)carbamate (diastereomeric ratio (dr)>10:1 by 1H-NMR) as the main product. This crude was purified by flash chromatography (cyclohexane/ethyl acetate) affording tert-butyl (( S)-4-methyi-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate (4.04 g, 40percent yield) as an oil 1H-NMR (400 MHz, CDCb) d 4.84 (d, J =8Hz, 1 H), 4.32 (ddd, J = 12, 10.4 and 3.2 Hz, 1 H), 3.29 (d, J = 4.8 Hz, 1 H), 2.88 (d, J = 4.8 Hz, 1 H), 1.72 (m, 1 H), 1.49 (s, 3 H), 1.45 (m, 1 H), 1.17 (ddd, J= 14.4, 10.4 and 4.2 Hz, 1 H), 0.97 (d, J= 6.8 Hz, 3 H), 0.93 (d, J= 6.8 Hz, 3 H). Analysis GC (optical purity) 96percent ee
20.8 g With calcium hypochlorite In 1-methyl-pyrrolidin-2-one; water at -15 - 0℃; for 0.333333 h; Water (214 mL) was added to a three neck flask equipped with a mechanical stirrer, an addition funnel, and a thermocouplewith display and cooled to an internal temperature of -5 to 0 °C. Solid calcium hypochlorite (107 g, 748 mmol) was thenadded over approximately 5 minutes, while the temperature of the mixture is maintained at approximately -5°C to 0°C.The mixture was then further cooled to -10°C to -5°C and stirred for 10 minutes followed by addition of NMP (1000 mL)via addition funnel at a rate to maintain internal temperature between -10 °C to -5 °C. The reaction slurry was then stirredat -10 °C for 15 minutes. (R) (47.8 g, 187 mmol) was dissolved in NMP (40 0mL) and added dropwise to the reactionmixture while maintaining the internal temperature between -15 °C and -10 °C. The reaction mixture was then stirred at-5 °C to 0 °C until the reaction was complete by TLC. Upon reaction completion, the mixture was quenched by slowaddition of 1.0 M sodium thiosulfate solution (500 mL), maintaining an internal temperature of -10 °C to -5 °C. Ethyl Acetate (1000 mL) was then added, the layers were separated and the aqueous layer was extracted twice more. Thecombined organic layers were washed with water (500 mL) and brine (500 mL), dried over magnesium sulfate, filteredand concentrated under reduced pressure to a to yellow oil which was dissolved in hexanes (600 mL) and filtered througha plug of silica to provide (H) as a pale yellow oil (20.8 g).
16.5 g With dihydrogen peroxide; potassium carbonate; benzonitrile In methanol at 25 - 30℃; for 6 h; A mixture of (S)-tert-butyl 2,6-dimethyl-3-o ohept-l-en-4-ylcarbamate (50 gm), methanol (1250 ml) and potassium carbonate (13.5 gm) was stirred for 15 min at 25-30°C. Benzonitrile (10.1 gm) was added to the reaction mixture and cooled to 0-5°C. 50percent hydrogen peroxide (1.6 gm) was slowly added to the reaction mixture at 0-5°C and raised the temperature of the reaction mixture to 25-30°C. Second lot of 50percent hydrogen peroxide (25 gm) was slowly added to the reaction mixture at 25-30°C and stirred for 6 hrs at the same temperature. The obtained reaction mixture was slowly added to a pre-cooled solution of sodium thiosulfate and water at 0-5°C and stirred the reaction mixture for 20 min at the same temperature. Raised the temperature of the reaction mixture to 25-30°C, dichloromethane was added and stirred for 15 min at the same temperature. Both the organic and aqueous layers were separated and the organic layer was washed with aqueous sodium thiosulfate solution. Distilled off the solvent completely from the organic layer under reduced pressure and the obtained compound was purified by column chromatography using ethyl acetate: cyclohexane as eluent. Yield: 16.5 gm

Reference: [1] Patent: CN104672179, 2017, B, . Location in patent: Paragraph 0009; 0024; 0025; 0027-0043
[2] Patent: WO2018/100050, 2018, A1, . Location in patent: Page/Page column 15; 16; 17; 18
[3] ChemBioChem, 2012, vol. 13, # 6, p. 810 - 817
[4] Patent: WO2013/9923, 2013, A1, . Location in patent: Sheet 4; 5
[5] Bioorganic and Medicinal Chemistry, 2018,
[6] Patent: WO2014/18807, 2014, A1, . Location in patent: Paragraph 00112; 00115
[7] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 11, p. 2955 - 2965
[8] Organic and Biomolecular Chemistry, 2014, vol. 12, # 30, p. 5710 - 5718
[9] Chemistry and Biology, 2014, vol. 21, # 6, p. 782 - 791
[10] Journal of Chemical Research, 2016, vol. 40, # 2, p. 82 - 86
[11] Patent: KR2015/131405, 2015, A, . Location in patent: Paragraph 0554-0557
[12] Patent: WO2016/170544, 2016, A1, . Location in patent: Page/Page column 36
[13] Patent: WO2016/185450, 2016, A1,
[14] Patent: CN105017181, 2017, B,
[15] European Journal of Medicinal Chemistry, 2019, vol. 161, p. 416 - 432
  • 14
  • [ 247068-81-1 ]
  • [ 247068-82-2 ]
YieldReaction ConditionsOperation in experiment
48% at 0 - 4℃; for 43 h; Alkaline aqueous solution For example, for an epoxomicin synthesis, a typical epoxidizing reagent (for example, alkaline hydrogen peroxide) can be reacted with the ?','-unsaturated ketone described above, in polar solvent (for example, aqueous solution or methanol in water) in the presence of a compound which gives a reactive intermediate, which reacts with the unsaturated ketone to give an epoxide product (for example, benzonitrile), and a moderately hindered base (for example, i-Pr2Net) at moderately low temperature (for example, 0 to 4 C.), for at least about 10 hours (for example, 43 hours) to give the ?','-epoxy ketone in good yield (for example, 76percent). For example, in the above synthesis of epoxomicin using Boc-protected Leu, the ratio of compound having the (R) ?' carbon to the compound having the (S) ?' carbon was 1.7:1. The same synthesis using Z-protected Leu gave a 4.0:1 (R):(S) ratio. These compounds were readily separated, for example by flash chromatography, in common solvent systems, for example hexanes:EtOAc 10:1).
0.059 g With pyridine; sodium hypochlorite In water at -5 - 0℃; for 2 h; To a -5 °C solution of (R) (0.200 g, 0.78 mmol) in pyridine (3 mL) was added 10percent aqueous NaOCl (1.5 mL)dropwise at a rate such that the internal reaction temperature remained below -4 °C. After the addition of NaOCl wascomplete, the reaction flask was placed in a 0 °C bath and stirred for two hours. The mixture was then diluted with EtOAc(10 mL), washed with water (2 x 10 mL), brine (2 x 10 mL) and dried over Na2SO4. The Na2SO4 was removed by filtrationand the volatiles removed under reduced pressure to give the crude mixture of (H) and (Q). Purification by flash chro-matography (20:1 hexanes/ EtOAc) gave (H) as an oil (0.059 g, 0.216 mmol) and (Q) as a solid (0.023 g, 0.085 mmol).
86 % ee With (R)-La-BINOL; triphenylphosphine; <i>tert</i>-butyl alcohol In toluene at 20℃; for 0.5 h; Compound III (102 g, 0.4 mol), asymmetric chiral catalyst (R) -La-BINOL (3.24 g, 2 molpercent) was added to a 1 L reaction flask,Triphenylphosphine (14.8 g, 20 molpercent), 500 mL of toluene, and stirred at room temperature.Then, tert-butanol (108 g, 1.2 mol) was slowly added dropwise. After 0.5 h of reaction, TLC was monitored and the reaction was complete. The reaction solution was filtered and the filtrate was collected.The filtrate was quenched with 300 mL of saturated sodium sulfite solution. The tetrahydrofuran was evaporated under reduced pressure and then extracted with 400 mL of ethyl acetate. The organic phase was washed successively with 100 mL of water, 100 ml of saturated brine, dried over anhydrous sodium sulfate and dried under reduced pressure. 92 g of a pale yellow oil, which was Compound I, yield 85.0percent and ee was 93percent.
51.22 % de With C28H34F6MnN6O6S2; dihydrogen peroxide; acetic acid In acetonitrile at -20℃; for 1 h; A 10 mL reaction tube was provided, to which was added compound Boc-1 (0.5 mmol, 127.5 mg), acetic acid (2.5 mmoia 43yL), 1 mL of acetonitrile solution, catalyst C2-3 (0.0025 mmol), and stirred at -20 °C. .30percent hydrogen peroxide (1.0 mmol, 100 μL) was dissolved in 1 ml of acetonitrile, and slowly added dropwise to the reaction system, and the addition was completed in one hour. Stirring was continued for one hour and the reaction was completed. The reaction was quenched by adding an appropriate amount of sodium thiosulfate, dried over anhydrous sodium sulfate, filtered, and then evaporated(ethyl acetate: petroleum ether = 1:100), an oily liquid,The yield of the two configuration mixtures was 97percent.The ratio of the target epoxide Boc-2 (R configuration) and its isomer compound Boc-3 (S configuration) R: S = 1:3.1.
35.484 % de With C28H34F6MnN6O6S2; dihydrogen peroxide; acetic acid In acetonitrile at -20℃; for 2 h; General procedure: General procedure for the catalytic epoxidation of the vinyl ketone 1.To a 10 mL tube was first charged with tert-butyl (S)-(2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate (0.5 mmol, 128mg), Mn catalysts (0.5 molpercent), HOAc (5 equiv, 143 μL) and CH3CN (1.0 mL). Then the mixture was cooled to -20C and H2O2 (2 equiv, 30percent diluted with 0.5 mL of CH3CN) was added dropwise through a syringe pump over 60min, followed by an additional 60 min of stirring. When the reaction was completed, the resulting mixture wasquenched with Na2S2O3 and dried over anhydrous Na2SO4, after that, the solvent was removed under reducedpressure. The residue was purified by column chromatography on silica gel with petroleum ether and ethyl acetate(1:100-1:80) to give the corresponding product.1.Analytical data for the epoxyketone 2 and the newly synthesized ligands.tert-butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate colorless transparent oily liquid. 1H NMR (400 MHz, Chloroform-d) δ: 4.90 (d, J = 8.5 Hz, 1H), 4.26 (t, J = 9.5 Hz,1H), 3.24 (d, J = 4.8 Hz, 1H), 2.83 (d, J = 5.0 Hz, 1H), 1.69-1.64 (m, 1H), 1.46-1.40 (m, 4H), 1.35 (s, 9H), 1.17-1.09(m, 1H), 0.91 (d, J = 8.0 Hz, 3H), 0.88 (d, J = 8.0 Hz, 3H). 13C NMR (400 MHz, Chloroform-d) δ: 207.9,155.3,79.8,58.7, 52.8, 41.0, 29.7, 28.3, 24.9, 23.4, 21.5, 17.6. tert-butyl ((S)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate light yellow solid. 1H NMR (400 MHz, Chloroform-d) δ 4.89 (s, 1H), 4.54 (s, 1H), 3.01 (s, 1H), 2.84 (s, 1H),1.68-1.65 (m, 1H), 1.53 (s, 3H), 1.33-1.24 (m, 2H), 0.95 (d, J = 4 Hz, 3H), 0.90 (d, J = 8.0 Hz, 3H). 13C NMR (400MHz, Chloroform-d) δ: 209.7, 155.7, 79.8, 59.1, 52.4, 51.5, 40.4, 29.8, 28.4, 25.2, 23.5, 21.4, 16.9.

Reference: [1] Patent: US6831099, 2004, B1, . Location in patent: Page column 14, 16
[2] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 15, p. 2283 - 2288
[3] Chemistry - A European Journal, 2012, vol. 18, # 22, p. 6750 - 6753
[4] Patent: KR2015/131405, 2015, A, . Location in patent: Paragraph 0535-0539
[5] Patent: CN104672179, 2017, B, . Location in patent: Paragraph 0024; 0025; 0027-0043
[6] Patent: WO2018/27021, 2018, A1, . Location in patent: Page/Page column 37
[7] Patent: WO2018/100050, 2018, A1, . Location in patent: Page/Page column 18; 19
[8] Patent: CN108373456, 2018, A, . Location in patent: Page/Page column 6-9; 10; 11; 12; 13
[9] Chinese Chemical Letters, 2018,
  • 15
  • [ 247068-81-1 ]
  • [ 247068-82-2 ]
Reference: [1] Patent: CN104672180, 2017, B, . Location in patent: Paragraph 0010; 0031-0034; 0036-0041; 0052-0057; 0070-0073
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 247068-81-1 ]

Carfilzomib Related Intermediates

Chemical Structure| 100564-78-1

[ 100564-78-1 ]

(S)-2-((tert-Butoxycarbonyl)amino)-4-phenylbutanoic acid

Chemical Structure| 868540-16-3

[ 868540-16-3 ]

(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid

Chemical Structure| 3235-69-6

[ 3235-69-6 ]

Morpholin-4-yl-acetic acid

Chemical Structure| 868539-96-2

[ 868539-96-2 ]

(6S,9S,12S)-Methyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate

Chemical Structure| 247068-82-2

[ 247068-82-2 ]

tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate

Related Functional Groups of
[ 247068-81-1 ]

Alkenes

Chemical Structure| 193751-54-1

[ 193751-54-1 ]

tert-Butyl cyclopent-3-en-1-ylcarbamate

Similarity: 0.69

Chemical Structure| 1012341-48-8

[ 1012341-48-8 ]

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid

Similarity: 0.68

Chemical Structure| 168960-18-7

[ 168960-18-7 ]

tert-Butyl ((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)carbamate

Similarity: 0.68

Chemical Structure| 168683-02-1

[ 168683-02-1 ]

(1S,4R)-Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate

Similarity: 0.66

Chemical Structure| 159635-49-1

[ 159635-49-1 ]

tert-Butyl 4-methylenepiperidine-1-carboxylate

Similarity: 0.66

Aliphatic Chain Hydrocarbons

Chemical Structure| 497861-77-5

[ 497861-77-5 ]

(R)-tert-Butyl (4-oxobutan-2-yl)carbamate

Similarity: 0.72

Chemical Structure| 186743-06-6

[ 186743-06-6 ]

tert-Butyl (4-oxobutan-2-yl)carbamate

Similarity: 0.72

Chemical Structure| 170384-29-9

[ 170384-29-9 ]

tert-Butyl (2-oxopropyl)carbamate

Similarity: 0.71

Chemical Structure| 133467-01-3

[ 133467-01-3 ]

Boc-D-Leu-OMe

Similarity: 0.71

Chemical Structure| 67706-68-7

[ 67706-68-7 ]

Ethyl 4-((tert-butoxycarbonyl)amino)-3-oxobutanoate

Similarity: 0.70

Amides

Chemical Structure| 291533-10-3

[ 291533-10-3 ]

tert-Butyl (2-oxocyclohexyl)carbamate

Similarity: 0.88

Chemical Structure| 741737-30-4

[ 741737-30-4 ]

tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate

Similarity: 0.79

Chemical Structure| 885280-38-6

[ 885280-38-6 ]

tert-Butyl (3-oxocyclohexyl)carbamate

Similarity: 0.79

Chemical Structure| 116437-41-3

[ 116437-41-3 ]

tert-Butyl (4-oxo-4-phenylbutyl)carbamate

Similarity: 0.78

Chemical Structure| 163513-98-2

[ 163513-98-2 ]

(1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane

Similarity: 0.78

Ketones

Chemical Structure| 291533-10-3

[ 291533-10-3 ]

tert-Butyl (2-oxocyclohexyl)carbamate

Similarity: 0.88

Chemical Structure| 741737-30-4

[ 741737-30-4 ]

tert-Butyl 2-methyl-3-oxopiperidine-1-carboxylate

Similarity: 0.79

Chemical Structure| 885280-38-6

[ 885280-38-6 ]

tert-Butyl (3-oxocyclohexyl)carbamate

Similarity: 0.79

Chemical Structure| 116437-41-3

[ 116437-41-3 ]

tert-Butyl (4-oxo-4-phenylbutyl)carbamate

Similarity: 0.78

Chemical Structure| 163513-98-2

[ 163513-98-2 ]

(1R,4S)-7-Boc-2-oxo-7-azabicyclo[2.2.1]heptane

Similarity: 0.78

Amines

Chemical Structure| 291533-10-3

[ 291533-10-3 ]

tert-Butyl (2-oxocyclohexyl)carbamate

Similarity: 0.88

Chemical Structure| 116437-41-3

[ 116437-41-3 ]

tert-Butyl (4-oxo-4-phenylbutyl)carbamate

Similarity: 0.78

Chemical Structure| 400899-84-5

[ 400899-84-5 ]

tert-Butyl methyl(4-oxocyclohexyl)carbamate

Similarity: 0.75

Chemical Structure| 247068-82-2

[ 247068-82-2 ]

tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate

Similarity: 0.74

Chemical Structure| 92235-39-7

[ 92235-39-7 ]

(S)-tert-Butyl (2-oxopiperidin-3-yl)carbamate

Similarity: 0.73